• PDtrials - Parkinson's Disease Clinical Trials
• /Browse By Type
• /Observation (No intervention)

Official Study Title: Cognitive  CognitiveRelated to mental activities having to do with perception, memory, judgment, and reasoning. Impairment and Cognitive Training among Persons with Parkinson's Disease
Sponsor: National Institute on Aging (NIA)
Clinicaltrials.gov ID:
Study ID:

Summary

The purpose of this study is to explore how cognitive abilities, such as mental quickness, memory, attention, and everyday activities, are affected by Parkinson's disease.  Parkinson's DiseaseA chronic, slowly progressive disease of the nervous system characterized by the combination of tremor, rigidity, bradykinesia and stooped posture, among other symptoms.   PD is a chronic, slowly progressive disease of the nervous system characterized by the combination of tremor,  TremorShaking or rhythmic movement, especially in the hands but in other parts of the body. Often occurs when at rest, such as in the RESTING TREMOR. rigidity,  RigidityA symptom in which muscles feel stiff and display resistance to movement even when another person tries to move the affected part of the body. bradykinesia  BradykinesiaSlowness of movement. and stooped posture, among other symptoms. The researchers will test cognitive training programs (which are non-invasive and non-pharmacological) to see if such programs can improve cognition, depression, and everyday function. The ultimate goal of the research is to help people with PD maintain their functioning and independence. Participation involves one to three testing sessions, which will take place at the University of South Florida (USF) Cognitive Aging Lab, the USF Movement Disorders Clinic in Tampa, or an approved off-site location. Each session will last between 1½  to 3 hours and will be scheduled at times convenient to the participant. During these sessions, participants will answer questions about their PD diagnosis. Participants will also be asked to read eye charts, complete paper-and-pencil tests of memory and reasoning, and respond to a visual attention task on the computer. No computer experience is necessary, and a research assistant will provide guidance throughout each procedure. Some participants may be invited to complete a cognitive training program. Participants are randomized to complete the program after the first visit or after the second visit.

Study Phase

Phase 1
What is a study phase?

Symptoms Addressed: Non-movement Symptoms

Memory

Time Commitment

• More than six months
• Three study visits.

Eligibility

• Minimum Age: 40
• Gender(s) Accepted: Either

Inclusion Criteria

• Corrected visual acuity of 20/50 or better
• English-speaking
• Clinical  ClinicalDealing with or based on observation and treatment of people, as opposed to basic science carried out in the laboratory or in animals. diagnosis of PD
• Stable medication regimen (no expected changes in the next six months)
• No random or severe motor fluctuations and dyskinesias

Exclusion Criteria

• Severe dementia

Enrollment

Expected Enrollment: 150 (US)
Date Enrollment Began: Oct 2007
Date Enrollment Ends: Dec 2011
Last Updated Date: Apr 25 2011
Trial Post Date: Jan 14 2008
Website:

Primary Contacts and Locations

Florida

• USF Cognitive Aging Lab
  usfcognitiveagelab@gmail.com
  Phone: (813) 974-6703
  School of Aging Studies
  13301 Bruce B. Downs Blvd., MHC 1304
  Tampa, FL 33612
  USA
  

View All Locations and Contacts